Arcutis Biotherapeutics Reports Inducement Grants Under : vi

WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...

Related Keywords

Derek Cole , Amanda Sheldon , Latha Vairavan , Compensation Committee Of Arcuti Board Directors , Arcutis Biotherapeutics Inc , Facebook , Nasdaq , Investor Relations Advisory Solutions , Exchange Commission , Head Of Corporate Communications , Compensation Committee , Arcuti Board , Nasdaq Listing Rule , Private Securities Litigation Reform Act , Vice President , Relations Advisory , Nasdaq Arqt , Arcutis Biotherapeutics , Nc ,